1. Kumar, S., Ramasamy, K., Natarajan, H., Venkatraman, S., Eriyat, V., & Kundra, P.  Impact of genetic variants on fentanyl metabolism in major breast surgery patients: a candidate gene association study. Pharmacogenomics, 2024 25(14), 595–603. https://doi.org/10.1080/14622416.2024.2429365
2. Gopinath S, Shewade DG, Dubashi B, Kadambari D, Ramesh A, Kesavan R. Deletion of GSTM1 associated with better pathological response in locally advanced breast cancer patients of south indian population. African Journal of Biological Sciences. 2024;6(11):1062-72. doi:10.33472/AFJBS.6.11.2024.1062-72
3. Reddy, Aditya V., Kesavan, Ramasamy, Priyadharsini, Rajendran and Deva, Reka. "Unlocking the therapeutic potential and personalized therapy of testosterone: a comprehensive review" Drug Metabolism and Personalized Therapy, 2024. https://doi.org/10.1515/dmpt-2024-0035
4. Venkatraman S, Ramasamy K, Desingu R, Prasath D, Navinraja KV, Selvam P. Operation anti‑microbial resistance intervention for total health path forward. Natl J Pharmacol Ther 2024 DOI: 10.4103/NJPT.NJPT_36_24
5. Venkatraman S, Ramasamy K. Pharmacology of Connexins-Still a Gap. J Young Pharm. 2024;16(2):139-44.
6. Dhivya, Elango, Kesavan, Ramasamy and Pradeep, Nair P.. "Impact of ABCB1 genetic polymorphism on carbamazepine dose requirement among Southern Indian persons with epilepsy" Drug Metabolism and Personalized Therapy, 2024. https://doi.org/10.1515/dmpt-2023-0054
7. Deva, Reka, Rajendran, Priyadharsini, Ramasamy, Sivaranjani, Selvan, Senthamizh and Ramasamy, Kesavan. Association of ITPA 94C>A genetic polymorphisms with azathioprine induced adverse effects in the South Indian population" Drug Metabolism and Personalized Therapy, 2023. https://doi.org/10.1515/dmpt-2023-0061
8. Ramakrishnan K, Kesavan R, Venkatraman S, Narayan SK, Kumar RR, Shewade D. Impact of CYP2C9*2 and *3 polymorphisms on valproate-associated adverse drug reactions in individuals living with epilepsy: a case-control study. Per Med. 2023 Oct 9. doi: 10.2217/pme-2023-0033.
9. Venkatraman S, Ramasamy K, Nair PP. Genetic polymorphisms of microsomal epoxide hydrolase and UDP‑glucuronosyltransferase (UGT) and its effects on plasma carbamazepine levels and metabolic ratio in persons with epilepsy of South India: A cross‑sectional genetic association study. Indian J Pharmacol 2023;55:149-54.
10. Devanathan R, Alladi CG, Ravichandran M, Ramasamy K, Uppugunduri CRS. Impact of pharmacogenomics in achieving personalized/precision medicine in the clinical setting: a symposium report. Pharmacogenomics. 2023;24:123-9.
11. Venkatraman S, Ramasamy K. Precision medicine-where do we stand now and what lies ahead us? Int J Basic Clin Pharmacol 2023;12:616-20
12. Venkatraman S, Ramasamy K, Nair PP, Rajendran P. Influence of EPHX1 c.337 T>C and UGT2B7*2 genetic polymorphisms on the requirement of carbamazepine maintenance dose in person with epilepsy (PWE) of Southern part of India: a cross-sectional genetic association study. Drug Metab Pers Ther. 2023;38:191-7
13. Kumar S, Kesavan R, Sistla SC, Penumadu P, Natarajan H, Nair S, Chakradhara Rao US, Venkatesan V, Kundra P. Impact of Genetic Variants on Postoperative Pain and Fentanyl Dose Requirement in Patients Undergoing Major Breast Surgery: A Candidate Gene Association Study. Anesth Analg. 2022;137:409-17.
14. Kumar S, Kesavan R, Sistla SC, Penumadu P, Natarajan H, Nair S, Chakradhara Rao US, Venkatesan V, Kundra P. Predictive models for fentanyl dose requirement and postoperative pain using clinical and genetic factors in patients undergoing major breast surgery. Pain 2022:164:1332–9.
15. Shravan V, Ramasamy K. Ghrelin and Its Role in Therapeutics. Int J Sci Stud 2022;10:32-8
16. Priyadharsini R, Ramasamy K, Amarendar S. Antibiotic-prescribing pattern in the outpatient departments using the WHO prescribing indicators and AWaRe assessment tool in a tertiary-care hospital in South India. Journal of Family Medicine and Primary Care. 2022;11:74-8.
17. Meena DK, Jayanthi M, Ramasamy K, Thulasingam M. Medicine Storage and Dispensing Facilities in Public Healthcare Pharmacies of Puducherry, India. Cureus. 2022;14:e21389.
18. Xaviar S, Kumar S, Ramasamy K, Chakradhara Rao US. Indo-Swiss symposium on advances in pharmacogenomic strategies for implementation of personalized medicine. Pharmacogenomics. 2021;22:67-71.
19. Thakkar DN, Ramasamy K, Adithan S, Selvarajan S, Dubashi B. Frequency and risk factors of bleomycin-induced pulmonary toxicity in South Indian patients with germ-cell tumors. Journal of Cancer Research and Therapeutics. 2021;17(2):443-9
20. Meena DK, Mathaiyan J, Thulasingam M, Ramasamy K. Assessment of medicine use based on WHO drug-use indicators in public health facilities of the South Indian Union Territory. Br J Clin Pharmacol. 2021;88:2315-26
21. Meena DK, Jayanthi M, Ramasamy K, Mahalakshmi T. Availability of Key Essential Medicines in Public Health Facilities of South Indian Union Territory: One of the Crucial Components of Universal Health Coverage. Cureus. 2021;13(11):e19419.
22. Mani B, Nair PP, Sekhar A, Kamalanathan S, Narayan SK, Kesavan R. CYP2C19 & UGT1A6 genetic polymorphisms and the impact on Valproic acid-induced weight gain in people with epilepsy: Prospective genetic association study. Epilepsy Res. 2021;177:106786.
23. Thakkar DN, Prapath I, Adithan S, Ramasamy K, Selvarajan S, Dubashi B. Variants in XPC, Noxa and TLR4 genes are not associated with bleomycin-induced lung injury in Hodgkin lymphoma patients. Per Med. 2020;17:203-12.
24. Priyadharsini RP Kesavan R. Antibiotic prescribing pattern among paediatric patients attending tertiary care hospital in South India. Int J Basic Clin Pharmacol. 2020;9:1028-31.
25. Kumar S, Kundra P, Ramsamy K, Surendiran A. Pharmacogenetics of opioids: a narrative review. Anaesthesia. 2019;74(11):1456-70.

List of Full Publications details :

https://scholar.google.com/citations?user=R60l3eEAAAAJ&hl=en